Drugs / encainide
encainide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00000504 | Sep 1982 → Sep 1985 | cardiac rhythm disease | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00000526 | Aug 1986 → Mar 1998 | cardiac arrest, coronary artery disorder, myocardial infarction, myocardial ischemia +1 | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | encainide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000504 ↗ |
| Known as | Encainida | ChEMBL registry synonym — accepted as the source's own label CHEMBL315838 ↗ |
| Known as | Encainide hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL315838 ↗ |
| Known as | ENCAINIDE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL315838 ↗ |
| Known as | Enkaid | ChEMBL registry synonym — accepted as the source's own label CHEMBL315838 ↗ |
| Known as | MJ 9067-1 | ChEMBL registry synonym — accepted as the source's own label CHEMBL315838 ↗ |
| Known as | MJ-9067 | ChEMBL registry synonym — accepted as the source's own label CHEMBL315838 ↗ |
| Modality | Small molecule | — CHEMBL315838 ↗ |